For example, upregulation of clathrin light-chain (CLCb) leads to an increased rate of CME; this in turn alters the trafficking of oncogenic epidermal growth factor receptor (EGFR) and promotes cancer cell migration and metastasis [112]. This evidence concerns the gene EGFR and cancer.